We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Brain Development Research Program

This study is currently recruiting participants.
Verified January 2017 by University of California, San Francisco
Sponsor:
ClinicalTrials.gov Identifier:
NCT00305305
First Posted: March 21, 2006
Last Update Posted: January 11, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
University of Washington
California Institute of Technology
Information provided by (Responsible Party):
University of California, San Francisco
March 17, 2006
March 21, 2006
January 11, 2017
August 2003
January 2018   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00305305 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Brain Development Research Program
Disorders of Cerebral Development: A Phenotypic and Genetic Analysis
Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of brain development that affect the corpus callosum, such as Aicardi syndrome, as well as two additional brain malformations, polymicrogyria and Dandy-Walker malformation. The goal of the investigators' research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients.
We are studying both the genetics and clinical features of these disorders. We hope to understand the problems faced by individuals with these disorders as well as their causes. In the future, we hope to develop therapies that are geared specifically for individuals based on the underlying biology. To participate in the study, you will be asked to provide a copy of the magnetic resonance imaging (MRI) documenting Agenesis Corpus Callosum (ACC), Polymicrogyria (PMG), or Dandy-Walker malformation (DWM), clinical information, and blood samples from the affected individual and from the parents. Please see contact information and our webpage below.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Individuals with agenesis or dysgenesis of the corpus callosum, polymicrogyria, or cerebellar hypoplasia.
  • Brain Disorders
  • Aicardi Syndrome
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
2000
January 2018
January 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of agenesis or dysgenesis of the corpus callosum, polymicrogyria, or Dandy-Walker malformation
  • Should be confirmed by an MRI (Magnetic Resonance Imaging) of the brain

Exclusion Criteria:

  • Fully formed but hypoplastic corpus callosum
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact: Brieana Fregeau, BA 7605338985 brieana.fregeau@ucsf.edu
United States
 
 
NCT00305305
UCSF-PCRC #2206
Not Provided
Not Provided
Not Provided
University of California, San Francisco
University of California, San Francisco
  • University of Washington
  • California Institute of Technology
Principal Investigator: Elliott H Sherr, MD, PhD University of California, San Francisco
Principal Investigator: James Barkovich, MD University of California, San Francisco
Principal Investigator: Pratik Mukherjee, MD, PhD University of California, San Francisco
University of California, San Francisco
January 2017